MedTrace Logo

Shrunken Pore Syndrome: a Retrospective, Single Center, Cohort Study

NCT04141072 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4719

Last updated 2021-09-21

No results posted yet for this study

Summary

To study the impact a difference in renal clearance of small and large molecules has on long-term survival.

Conditions

Interventions

DIAGNOSTIC_TEST

Shrunken Pore Syndrome

eGFR Cystatin C ≤ 60% of eGFR Creatinine

Sponsors & Collaborators

  • Henrik Bjursten

    lead OTHER

Principal Investigators

  • Henrik Bjursten, MD PhD · Region Skåne

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-01
Primary Completion
2015-12-30
Completion
2019-01-10

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04141072 on ClinicalTrials.gov